| 1. |
Brady M, Main J. Aciclovir neurotoxicity is an important side effect of therapy in patients with renal impairment[J]. Clin Med, 2009, 9(6):630.
|
| 2. |
Helldén A, Odar-Cederl?f I, Diener P, et al. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects:an observational study[J]. Nephrol Dial Transplant, 2003, 18(6):1135-1141.
|
| 3. |
Basler M, Lauer C, Beck U, et al. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection[J]. J Immunol, 2009, 183(10):6145-6150.
|
| 4. |
Gilden DH, Cohrs RJ, Mahalingam R. Clinical and molecular pathogenesis of varicella virus infection[J]. Viral Immunol, 2003, 16(3):243-258.
|
| 5. |
Dasanu CA, Alexandrescu DT. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?[J]. J Oncol Pharm Pract, 2010, 16(4):266-268.
|
| 6. |
Minarik J, Pika T, Bacovsky J, et al. Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients[J]. Br J Haematol, 2012, 159(1):111-113.
|
| 7. |
Aoki T, Nishiyama T, Imahashi N, et al. Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients:a report from retrospective study[J]. Jpn J Clin Oncol, 2011, 41(7):876-881.
|
| 8. |
Gnann JW, Barton NH, Whitley RJ. Acyclovir:mechanism of action, pharmacokinetics, safety and clinical applications[J]. Pharmacotherapy, 1984, 3(5):275-283.
|
| 9. |
Blum MR, Liao SH, De Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children[J]. Am J Med, 1982, 73(1a):186-192.
|
| 10. |
De Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration[J]. J Antimicrob Chemother, 1983, 12(Suppl B):29-37.
|
| 11. |
Rashiq S, Briewa L, Mooney M, et al. Distinguishing acyclovir neurotoxicity from encephalomyelitis[J]. J Intern Med, 1993, 234(5):507-511.
|
| 12. |
Rajan GR, Cobb JP, Reiss CK. Acyclovir induced coma in the intensive care unit[J]. Anaesth Intensive Care, 2000, 28(3):305-307.
|
| 13. |
Ruiz-Roso G, Gomis A, Fernández-Lucas M, et al. Aciclovir and valaciclovir neurotoxicity in patients with renal failure[J]. Nefrologia, 2012, 32(1):114-115.
|
| 14. |
De Knegt RJ, Van Der Pijl H, Van Es LA. Acyclovir-associated encephalopathy, lack of relationship between acyclovir levels and symptoms[J]. Nephrol Dial Transplant, 1995, 10(9):1775-1777.
|
| 15. |
Tong Y, Qian J, Li Y, et al. The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients[J]. Am J Hematol, 2007, 82(5):403-404.
|
1/5
WeChat